Application Rates of Moringa (Moringa stenopetala) Leaf Powder Enhanced Maize Growth, Yield Components, and Soil Chemical Properties
National Academic Digital Repository of Ethiopia · 15.08.2024
DOI: 10.20372/afnr.v2i2.1145 ↗Kurz gefasst
Fachartikel in der Zeitschrift National Academic Digital Repository of Ethiopia, erschienen am 15.08.2024. Verfasst von Abdissa und 10 weiteren Autor:innen.
Abstract (Originalsprache)
This study was aimed to determine the effects of different rates of MLP application on maize growth, yield components, and soil chemical properties under greenhouse conditions. The experiment consisted of four treatments having 0 (control), 25g, 50g, and 75g of MLP, along with 2.1 g of Di-ammonium phosphate and 2.1g of UREA. The treatments were assigned in a randomized complete block design and replicated three times. The analysis of variance indicated that most maize growth parameters at 40, 70, and 100 days after planting (DAP) were significantly (P
Schlagwörter
Zitieren
APA
Abdissa, A., B., Abdissa, Ayansa, B., Dereje, Dawit, Feyisa, Adise, Gebiyaw, Fernuse, & Daba, G. (2024). Application Rates of Moringa (Moringa stenopetala) Leaf Powder Enhanced Maize Growth, Yield Components, and Soil Chemical Properties. National Academic Digital Repository of Ethiopia. https://doi.org/10.20372/afnr.v2i2.1145
Vancouver
Abdissa, A. B, Abdissa, Ayansa B, Dereje, Dawit, et al. Application Rates of Moringa (Moringa stenopetala) Leaf Powder Enhanced Maize Growth, Yield Components, and Soil Chemical Properties. National Academic Digital Repository of Ethiopia. 2024. doi:10.20372/afnr.v2i2.1145
BibTeX
@article{Abdissa2024,
author = {Abdissa and A., Biyeshi and Abdissa and Ayansa, Biyeshi and Dereje and Dawit and Feyisa and Adise and Gebiyaw and Fernuse and Daba, Gerba},
title = {Application Rates of Moringa (Moringa stenopetala) Leaf Powder Enhanced Maize Growth, Yield Components, and Soil Chemical Properties},
journal = {National Academic Digital Repository of Ethiopia},
year = {2024},
doi = {10.20372/afnr.v2i2.1145}
}
EUVIMED